Royce & Associates’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-577,703
| Closed | -$4.39M | – | 818 |
|
|
2025
Q1 | $4.39M | Sell |
577,703
-301,924
| -34% | -$2.29M | 0.05% | 467 |
|
|
2024
Q4 | $8.46M | Sell |
879,627
-93,226
| -10% | -$897K | 0.08% | 370 |
|
|
2024
Q3 | $5.75M | Buy |
972,853
+48,539
| +5% | +$287K | 0.05% | 446 |
|
|
2024
Q2 | $6.41M | Buy |
924,314
+27,698
| +3% | +$192K | 0.06% | 429 |
|
|
2024
Q1 | $6.9M | Buy |
896,616
+34,122
| +4% | +$263K | 0.06% | 429 |
|
|
2023
Q4 | $7.56M | Sell |
862,494
-5,500
| -0.6% | -$48.2K | 0.07% | 399 |
|
|
2023
Q3 | $6.33M | Sell |
867,994
-7,706
| -0.9% | -$56.2K | 0.06% | 423 |
|
|
2023
Q2 | $5.79M | Buy |
875,700
+33,700
| +4% | +$223K | 0.06% | 466 |
|
|
2023
Q1 | $2.87M | Buy |
842,000
+147,000
| +21% | +$501K | 0.03% | 607 |
|
|
2022
Q4 | $1.93M | Buy |
695,000
+150,000
| +28% | +$417K | 0.02% | 652 |
|
|
2022
Q3 | $1.56M | Buy |
+545,000
| New | +$1.56M | 0.02% | 663 |
|
|
2018
Q4 | – | Sell |
-4,336
| Closed | -$27K | – | 1182 |
|
|
2018
Q3 | $27K | Buy |
4,336
+2,035
| +88% | +$12.7K | ﹤0.01% | 1119 |
|
|
2018
Q2 | $15K | Buy |
2,301
+1,230
| +115% | +$8.02K | ﹤0.01% | 1176 |
|
|
2018
Q1 | $7K | Buy |
+1,071
| New | +$7K | ﹤0.01% | 1224 |
|